Key Highlights
- The hepatitis B vaccine has been recommended for newborns since the early 1990s.
- The vaccine is credited with a 99% reduction in acute hepatitis B infections in children.
- The upcoming vote could contradict previous public health advice regarding newborn vaccinations.
- Health Secretary Robert F. Kennedy Jr.'s committee is leading the review of the vaccine recommendation.
- Delaying the vaccine could potentially revive serious health risks associated with hepatitis B.
